Blue Crest Capital Management LTD Kiniksa Pharmaceuticals, Ltd. Put Options Transaction History
Blue Crest Capital Management LTD
- $2.15 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KNSA
# of Institutions
7Shares Held
1.9MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V81.52MShares$50.2 Million0.03% of portfolio
-
Spearhead Capital Advisors, LLC Wellington, FL203KShares$6.7 Million2.82% of portfolio
-
Harbor Capital Advisors, Inc.70.9KShares$2.35 Million0.08% of portfolio
-
Putnam Investments LLC Boston, MA39.5KShares$1.31 Million0.0% of portfolio
-
Birchview Capital, LP Burlington, VT30KShares$992,2980.6% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $1.14B
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...